The poor prognosis associated with the GBM mesenchymal subtype, and the link between IGFBP2 and key signature genes, such as STAT3[19] and VEGF[20], indicate that IGFBP2 is an important factor in the mesenchymal subtype of GBM[21]. The gene discussed is IGFBP2; the disease is glioblastoma.